TLSI Earnings

Quarterly EPS
$-0.12
Q3 2024
$-0.39
Q4 2024
$-0.39
Q1 2025
$-0.27
Q2 2025
$-0.96
Q3 2025
$-0.21
Q4 2025
$0.03
Q1 2026
$-0.16
Q2 2026
Latest Revenue11.4M
Latest Net Income-9187000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.1611.4M-9187000+1.7%+40.7%
Q1 2026$0.038.9M1.5M-2.9%+107.7%
Q4 2025-$0.2113.2M-9753000+59.8%+46.2%
Q3 2025-$0.9611.6M-10811000+57.4%-700.0%
Q2 2025-$0.2711.2M-8288000+52.3%-28.6%
Q1 2025-$0.399.2M-10375000+42.0%+35.0%
Q4 2024-$0.398.3M-10108000+44.4%+91.6%
Q3 2024-$0.127.3M-2399000+41.5%+14.3%
Q2 2024-$0.217.4M-4332000
Q1 2024-$0.606.5M-13206000
Q4 2023-$4.675.7M-35639000
Q3 2023-$0.145.2M-1425000
TriSalus Life Sciences (TLSI) — Earnings